haematology
Clotting disorders

Data mostly against vena cava filters for PE prevention


Early prophylactic use of retrievable vena cava filters after major trauma in patients with a contraindication to anticoagulation does not reduce the incidence of symptomatic pulmonary embolism (PE) or death at 90 days. Yet the filters are widely used for the prevention of PE in patients at high risk of bleeding. Speaking at the International ...

Already a member?

Enter your email to keep reading.


OR